Clinical Trials for Squamous Cell Lung Cancer

Phase II Study of Platinum (Cisplatin/Carboplatin)and Polymeric Micelles Paclitaxel(Pm-Pac) With Ivonescimab in First Line Metastatic Squamous NSCLC.

NCT ID: NCT07009925

This clinical trial is studying a new combination of treatments for patients with advanced squamous cell lung cancer, which is a type of lung cancer that has spread to other parts of the body. The ...

Trial of a Personalized and Adaptive Neoantigen Dose-Adjusted Vaccine Concurrently With Pembrolizumab

NCT ID: NCT04266730

This clinical trial is exploring a new treatment approach for patients with advanced squamous non-small cell lung cancer (NSCLC) or squamous cell carcinoma of the head and neck. The study will test...

A Study of ZEN003694 in People With Squamous Cell Lung Cancer

NCT ID: NCT05607108

This clinical trial is investigating a new drug called ZEN003694 as a potential treatment for people with advanced squamous cell lung cancer, specifically those whose cancer has a mutation in the N...

The Therapeutic Effect of Immunotherapy in Patients With Advanced Lung Squamous Carcinoma

NCT ID: NCT06647836

Therapeutic ResistAnce and Clonal Evolution Assessed With Liquid Biopsy in ICIs Treated NSCLC Patients

NCT ID: NCT04566432

This clinical trial is studying how well a blood test called ctDNA (circulating tumor DNA) can predict how lung cancer patients respond to treatments known as immune checkpoint inhibitors. These ar...

GPC3-CAR-T Cells for Immunotherapy of Cancer With GPC3 Expression

NCT ID: NCT03198546

This clinical trial is studying a new type of treatment for patients with advanced liver cancer, specifically those whose tumors express a protein called GPC3. The treatment involves using speciall...

APOLLO 11, Consortium of Italian Centers Involved in Treatment of Patients With Lung Cancer Treated With Innovative Therapies: Real World Data and Translational Reaserch

NCT ID: NCT05550961

The APOLLO 11 clinical trial is focused on improving how lung cancer is treated in Italy by collecting real-world data from around 48 medical centers across the country. Researchers want to build a...

CISH Inactivated TILs in the Treatment of NSCLC

NCT ID: NCT05566223

This clinical trial is exploring a new treatment for metastatic non-small cell lung cancer (NSCLC), which is a type of lung cancer that has spread to other parts of the body. The researchers are in...